MDT

88.75

+2.73%↑

A

116.89

+2.76%↑

VEEV

166.33

-3.59%↓

HQY

81.95

+1.22%↑

TLRY

6.75

+4.65%↑

MDT

88.75

+2.73%↑

A

116.89

+2.76%↑

VEEV

166.33

-3.59%↓

HQY

81.95

+1.22%↑

TLRY

6.75

+4.65%↑

MDT

88.75

+2.73%↑

A

116.89

+2.76%↑

VEEV

166.33

-3.59%↓

HQY

81.95

+1.22%↑

TLRY

6.75

+4.65%↑

MDT

88.75

+2.73%↑

A

116.89

+2.76%↑

VEEV

166.33

-3.59%↓

HQY

81.95

+1.22%↑

TLRY

6.75

+4.65%↑

MDT

88.75

+2.73%↑

A

116.89

+2.76%↑

VEEV

166.33

-3.59%↓

HQY

81.95

+1.22%↑

TLRY

6.75

+4.65%↑

Home・Aktien・Lisata Therapeutics

Search

L
Lisata Therapeutics

Geschlossen

5

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.99

Max

5

Schlüsselkennzahlen
By Trading Economics
Einkommen	1.3M -3M
Verkäufe	100K 100K
Gewinnspanne	-2,954
Angestellte	21

Dividenden
By Dow Jones
Nächstes Ergebnis	7. Mai 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-208K 39M
Vorheriger Eröffnungskurs	5
Vorheriger Schlusskurs	5

Lisata Therapeutics Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Apr. 2026, 20:44 UTC

Ergebnisse

Costco Reports 11% Growth in March Sales

8. Apr. 2026, 23:51 UTC

Market Talk

Global Equities Roundup: Market Talk

8. Apr. 2026, 23:51 UTC

Market Talk

Nikkei May Rise on Hopes for Talks to End Iran War -- Market Talk

8. Apr. 2026, 23:36 UTC

Market Talk

Wichtige Nachrichtenereignisse

Gold Edges Lower on Likely Technical Correction -- Market Talk

8. Apr. 2026, 22:56 UTC

Market Talk

Ramelius Resources May Downgrade Cost Guidance This Month -- Market Talk

8. Apr. 2026, 22:45 UTC

Market Talk

Constellation Brands Points to Continuing Challenges Among Hispanic Consumers -- Market Talk

8. Apr. 2026, 22:17 UTC

Market Talk

Applied Digital Says Its Holding Out for Quality Customers -- Market Talk

8. Apr. 2026, 21:52 UTC

Wichtige Nachrichtenereignisse

A Closer Look at Iran's 10 Demands -- and Which the U.S. Might Accept -- Update

8. Apr. 2026, 21:24 UTC

Ergebnisse

FedEx Freight Aims for 12% Profit Growth. How That Compares to the Leader. -- Barrons.com

8. Apr. 2026, 21:01 UTC

Wichtige Nachrichtenereignisse

Oil Prices Tumble Despite Conflicting Reports About the Strait of Hormuz -- Barrons.com

8. Apr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

8. Apr. 2026, 20:43 UTC

Akquisitionen, Fusionen, Übernahmen

Oracle Is Expressing No Opinion and Is Neutral as to Whether Stockholders Should Tender Their Shrs in Response to TRC's Offer >ORCL

8. Apr. 2026, 20:43 UTC

Akquisitionen, Fusionen, Übernahmen

Oracle Does Not Endorse TRC's Mini-Tender Offer or the Offer Documentation >ORCL

8. Apr. 2026, 20:43 UTC

Akquisitionen, Fusionen, Übernahmen

Oracle: Offer Represents Less Than 0.04% of Outstanding Common Stk >ORCL

8. Apr. 2026, 20:42 UTC

Akquisitionen, Fusionen, Übernahmen

Oracle: TRC Offer Is to Purchase Up to 1M Shrs of Common Stk at $140.50/Shr in Cash >ORCL

8. Apr. 2026, 20:42 UTC

Akquisitionen, Fusionen, Übernahmen

Oracle Received Notice of Unsolicited Mini-Tender Offer by TRC Dated March 24 >ORCL

8. Apr. 2026, 20:42 UTC

Akquisitionen, Fusionen, Übernahmen

Oracle Responds to TRC Cap Mini-Tender Offer

8. Apr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8. Apr. 2026, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

Intel Corp.: Repurchased 49% Equity Interest in JV Related to Intel's Fab 34 in Ireland >INTC

8. Apr. 2026, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

Intel Corp.: $14.2B Repurchase Price Financed with Cash on Hand and a Bridge Loan of $6.5B >INTC

8. Apr. 2026, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

Intel Corp.: Repurchased JV Stake From Apollo-Managed Funds and Affiliates >INTC

8. Apr. 2026, 19:44 UTC

Ergebnisse

These Companies Pay 5% Dividend Yields, and They're Hiking Them Too -- Barrons.com

8. Apr. 2026, 19:16 UTC

Market Talk

Hogs Follow Cutout Prices Lower -- Market Talk

8. Apr. 2026, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

8. Apr. 2026, 19:02 UTC

Market Talk

Oil Futures Plunge as Cease-Fire Raises Hopes for Restored Supply -- Market Talk

8. Apr. 2026, 18:58 UTC

Market Talk

U.S. Natural Gas Futures Fall in Line With Slump in Oil -- Market Talk

8. Apr. 2026, 18:51 UTC

Market Talk

Global Equities Roundup: Market Talk

8. Apr. 2026, 18:51 UTC

Market Talk

Levi Strauss CEO Says Expanded Offerings, DTC Focus Are Working -- Market Talk

8. Apr. 2026, 18:14 UTC

Wichtige Nachrichtenereignisse

Fed Minutes Suggest a Lengthy Iran War Could Lead to Rate Hikes -- Barrons.com

8. Apr. 2026, 18:05 UTC

Wichtige Nachrichtenereignisse

Oil Prices Continue to Tumble After Cease-Fire Despite Slow Reopening of Strait of Hormuz -- Barrons.com

Peer-Vergleich

Kursveränderung

Lisata Therapeutics Prognose

Rating-Konsens

By TipRanks

Neutral

1 ratings

0

Buy

1

Halten

0

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lisata Therapeutics – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

$

Über Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Andere Aktien aus dem Sektor

MDT

Medtronic PLC

88.75

A

Agilent Technologies Inc

116.89

VEEV

Veeva Systems Inc

166.33

HQY

HealthEquity Inc

81.95

TLRY

Tilray Brands Inc

6.75

Live chat